Recombinant Human Maspin (SERPINB5)
BackgroundMaspin is a tumor suppressor serine protease inhibitor (serpin) predominantly produced by myoepithelial cells, known for its ability to inhibit tumor cell motility, invasion, angiogenesis, and metastasis in various cancer models. Clinical research consistently links maspin expression to improved outcomes in cancers such as prostate, breast, and pancreatic cancer, where it plays a regulatory role in cell adhesion and apoptosis, as well as epithelial cell homeostasis. Importantly, maspin’s prognostic significance extends to pulmonary adenocarcinoma and non-small cell lung cancer, with higher nuclear maspin correlating with better patient survival rates and reduced tumor progression. Beyond its cytoplasmic and nuclear activities, maspin can be secreted via exosomes, suggesting potential applications in novel cancer diagnostics and therapeutics. Protein DetailsPurity >97% by SDS Page and HPLC Endotoxin Level <1.0 EU/µg Protein Accession No. P36952.2 Amino Acid Sequence MDALQLANSA FAVDLFKQLC EKEPLGNVLF SPICLSTSLS LAQVGAKGDT ANEIGQVLHF ENVKDIPFGF QTVTSDVNKL SSFYSLKLIK RLYVDKSLNL STEFISSTKR PYAKELETVD FKDKLEETKG QINNSIKDLT DGHFENILAD NSVNDQTKIL VVNAAYFVGK WMKKFPESET KECPFRLNKT DTKPVQMMNM EATFCMGNID SINCKIIELP FQNKHLSMFI LLPKDVEDES TGLEKIEKQL NSESLSQWTN PSTMANAKVK LSIPKFKVEK MIDPKACLEN LGLKHIFSED TSDFSGMSET KGVALSNVIH KVCLEITEDG GDSIEVPGAR ILQHKDELNA DHPFIYIIRH NKTRNIIFFG KFCSP.
State of Matter Lyophilized Predicted Molecular Mass The molecular weight of Recombinant Human Maspin is Mr 42.2 kDa. Formulation The protein was 0.2 µm filtered and lyophilized from PBS. Storage and Stability The lyophilized protein should be stored desiccated at -20°C. The reconstituted protein can be stored for at least one week at 4°C. For long-term storage of the reconstituted protein, aliquot into working volumes and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Leinco Protein AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Recombinant Human Maspin (SERPINB5) offers several compelling advantages for research applications, particularly in cancer biology, cell adhesion studies, and epithelial cell biology. Tumor Suppressor PropertiesMaspin functions as a non-inhibitory serpin with potent tumor suppressor activity. Unlike classical serpins, it does not undergo the conformational transition characteristic of active serine protease inhibitors, yet it effectively blocks the growth, invasion, and metastatic properties of mammary tumors. This unique mechanism makes it valuable for investigating tumor suppression pathways independent of protease inhibition. Cytoskeleton Interaction and Cell MorphologyOne of Maspin's most distinctive features is its direct interaction with the cytoskeleton. Recombinant Maspin binds to both F-actin and stabilized microtubules in the nanomolar range, suppressing microtubule growth at physiologically relevant concentrations. This capability enables researchers to study:
Cell Adhesion and Migration ModulationWhen added to cell culture medium, recombinant Maspin modulates cell adhesion and motility through interaction with the uPA/uPAR/β1-integrin complex at the cell surface. This makes it particularly useful for investigating:
Broad Cancer Research ApplicationsClinical research has consistently linked Maspin expression to improved outcomes across multiple cancer types, including breast, prostate, pancreatic, and lung cancers. This makes recombinant Maspin valuable for studying tumor suppression mechanisms in diverse cancer models and for developing therapeutic strategies targeting these pathways. Experimental VersatilityRecombinant Maspin is typically produced in bacterial expression systems and is available as a non-glycosylated protein of approximately 42.1 kDa containing 375 amino acid residues. Its availability in various formats (with or without affinity tags) allows for flexible experimental designs, including affinity purification studies to identify novel protein-protein interactions. You can use recombinant human Maspin (SERPINB5) as a standard for quantification or calibration in ELISA assays if the recombinant protein is of high purity, its concentration is accurately known, and it is compatible with the antibodies used in your specific ELISA system. However, there are important caveats and best practices to consider:
Best Practices:
Summary Table:
In summary, recombinant human Maspin can be used as a standard in ELISA, but only if you validate its performance in your specific assay context and ensure it is recognized equivalently to the standard provided by the kit or to native Maspin in your samples. Recombinant Human Maspin (SERPINB5) has been validated in published research for several key applications, primarily related to its roles in cell biology, cancer research, and cytoskeletal regulation. The main applications supported by the literature include:
These applications highlight the versatility of recombinant Maspin in both basic research and translational studies, particularly in the context of cancer biology and cytoskeletal regulation. To reconstitute and prepare Recombinant Human Maspin (SERPINB5) protein for cell culture experiments, dissolve the lyophilized protein in sterile, deionized water to achieve a stock concentration between 0.1–1.0 mg/mL. Mix gently to avoid foaming and ensure complete dissolution of the protein. Detailed protocol:
Preparation for cell culture:
Additional notes:
This protocol ensures optimal solubility and stability of recombinant Maspin for cell-based assays. References & Citations1. Craig AD. et al. (2003) J. Pathol. 199: 432 2. Zhang M. et al. (2008) Cancer Res. 68: 5143 3. Morohoshi T. et al. (2008) HBPD Int. 7: 86 4. Toshio et al. (2004) J. of Cancer Res. & Clin Oncol. 130: 475 5. ABRAHAM S, ZHANG W, GREENBERG N, ZHANG M. Maspin Functions as Tumor Suppressor by Increasing Cell Adhesion to Extracellular Matrix in Prostate Tumor Cells. Journal of Urology [Internet]. 2003 Mar 1 [cited 2025 Nov 19];169(3):1157–61. Available from: https://doi.org/10.1097/01.ju.0000040245.70349.37 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
Prod No. | Description |
|---|---|
LT610 | |
LT620 | |
F105 | |
42042 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
